UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Radiation damage and radioprotectants: new concepts in the era of molecular medicine

British journal of radiology, 2012-04, Vol.85 (1012), p.313-330

KOUKOURAKIS, M. I

2012

Volltextzugriff (PDF)

Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head–neck cancer

British journal of cancer, 2012-02, Vol.106 (5), p.846-853

2012

Volltextzugriff (PDF)

Lactate dehydrogenase 5 isoenzyme overexpression defines resistance of prostate cancer to radiotherapy

British journal of cancer, 2014-04, Vol.110 (9), p.2217-2223

2014

Volltextzugriff (PDF)

Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival

British journal of cancer, 2001-09, Vol.85 (6), p.881-890

2001

Volltextzugriff (PDF)

Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer

British journal of cancer, 2000-04, Vol.82 (8), p.1427-1432

2000

Volltextzugriff (PDF)

Hypoxia inducible factor 1α and 2α overexpression in inflammatory bowel disease

Journal of clinical pathology, 2003-03, Vol.56 (3), p.209-213

2003

Volltextzugriff (PDF)

Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis

British journal of cancer, 2003-09, Vol.89 (5), p.877-885

2003

Volltextzugriff (PDF)

Amifostine in clinical oncology: current use and future applications

Anti-cancer drugs, 2002-03, Vol.13 (3), p.181-209

Koukourakis, MI

2002

Volltextzugriff (PDF)

Prospective neoadjuvant analysis of PET imaging and mechanisms of resistance to Trastuzumab shows role of HIF1 and autophagy

British journal of cancer, 2014-04, Vol.110 (9), p.2209-2216

2014

Volltextzugriff (PDF)

Tumor microenvironment, immune response and post-radiotherapy tumor clearance

Clinical & translational oncology, 2020-12, Vol.22 (12), p.2196-2205

2020

Volltextzugriff (PDF)

High intratumoural accumulation of stealth® liposomal doxorubicin (Caelyx®) in glioblastomas and in metastatic brain tumours

British journal of cancer, 2000-11, Vol.83 (10), p.1281-1286

2000

Volltextzugriff (PDF)

Liposomal Doxorubicin and Conventionally Fractionated Radiotherapy in the Treatment of Locally Advanced Non–Small-Cell Lung Cancer and Head and Neck Cancer

Journal of clinical oncology, 1999-11, Vol.17 (11), p.3512-3521

1999

Volltextzugriff (PDF)

Proliferating fibroblasts at the invading tumour edge of colorectal adenocarcinomas are associated with endogenous markers of hypoxia, acidity, and oxidative stress

Journal of clinical pathology, 2005-10, Vol.58 (10), p.1033-1038

2005

Volltextzugriff (PDF)

Activated Vegfr2/kdr Pathway In Tumour Cells And Tumour Associated Vessels Of Colorectal Cancer

European journal of clinical investigation, 2007-11, Vol.37 (11), p.878-886

2007

Volltextzugriff (PDF)

Vascular density analysis in colorectal cancer patients treated with vatalanib (PTK787/ZK222584) in the randomised CONFIRM trials

British journal of cancer, 2012-09, Vol.107 (7), p.1044-1050

2012

Volltextzugriff (PDF)

Targeting the epigenome in malignant melanoma: Facts, challenges and therapeutic promises

Pharmacology & therapeutics (Oxford), 2022-12, Vol.240, p.108301-108301, Article 108301

2022

Volltextzugriff (PDF)

BNIP3 expression in endometrial cancer relates to active hypoxia inducible factor 1α pathway and prognosis

Journal of clinical pathology, 2008-02, Vol.61 (2), p.217-220

2008

Volltextzugriff (PDF)

Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia

British journal of cancer, 2010-10, Vol.103 (8), p.1209-1214

2010

Volltextzugriff (PDF)

Concurrent administration of Docetaxel and Stealth liposomal doxorubicin with radiotherapy in non-small cell lung cancer : excellent tolerance using subcutaneous amifostine for cytoprotection

British journal of cancer, 2002-08, Vol.87 (4), p.385-392

2002

Volltextzugriff (PDF)

LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer

Journal of clinical pathology, 2005-02, Vol.58 (2), p.202-206

2005

Volltextzugriff (PDF)

Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer

Clinical cancer research, 1998-12, Vol.4 (12), p.3017-3024

1998

Volltextzugriff (PDF)

Vascular endothelial growth factor (VEGF) expression in operable gallbladder carcinomas

European journal of surgical oncology, 2003-12, Vol.29 (10), p.879-883

2003

Volltextzugriff (PDF)

Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer

Clinical cancer research, 1997-12, Vol.3 (12), p.2485-2492

1997

Volltextzugriff (PDF)

Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancer

British journal of cancer, 1997-01, Vol.75 (4), p.477-481

1997

Volltextzugriff (PDF)

Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival

British journal of cancer, 1998-05, Vol.77 (10), p.1696-1703

1998

Volltextzugriff (PDF)

1 – 25 von 310

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(285)
Mit Volltextzugriff
(264)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Radiation damage and radioprotectants: new concepts in the era of molecular medicine

Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head–neck cancer

Lactate dehydrogenase 5 isoenzyme overexpression defines resistance of prostate cancer to radiotherapy

Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival

Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer

Hypoxia inducible factor 1α and 2α overexpression in inflammatory bowel disease

Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis

Amifostine in clinical oncology: current use and future applications

Prospective neoadjuvant analysis of PET imaging and mechanisms of resistance to Trastuzumab shows role of HIF1 and autophagy

Tumor microenvironment, immune response and post-radiotherapy tumor clearance

High intratumoural accumulation of stealth® liposomal doxorubicin (Caelyx®) in glioblastomas and in metastatic brain tumours

Liposomal Doxorubicin and Conventionally Fractionated Radiotherapy in the Treatment of Locally Advanced Non–Small-Cell Lung Cancer and Head and Neck Cancer

Proliferating fibroblasts at the invading tumour edge of colorectal adenocarcinomas are associated with endogenous markers of hypoxia, acidity, and oxidative stress

Activated Vegfr2/kdr Pathway In Tumour Cells And Tumour Associated Vessels Of Colorectal Cancer

Vascular density analysis in colorectal cancer patients treated with vatalanib (PTK787/ZK222584) in the randomised CONFIRM trials

Targeting the epigenome in malignant melanoma: Facts, challenges and therapeutic promises

BNIP3 expression in endometrial cancer relates to active hypoxia inducible factor 1α pathway and prognosis

Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia

Concurrent administration of Docetaxel and Stealth liposomal doxorubicin with radiotherapy in non-small cell lung cancer : excellent tolerance using subcutaneous amifostine for cytoprotection

LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer

Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer

Vascular endothelial growth factor (VEGF) expression in operable gallbladder carcinomas

Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer

Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancer

Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival

Suchergebnisse filtern